Джулия Эндерс - Внутрішня історія. Кишечник – найцікавіший орган нашого тіла

Hullar, M. A.; Lampe, J. W.:»The Gut Microbiome and Obesity«. In: Nestle Nutr Inst Workshop Ser. 2012; 73: S. 67–79.

Jernberg, C. et al.:»Long-Term Impacts of Antibiotic Exposure on the Human Intestinal Microbiota«. In: Microbiology. 2010 November; 156 (Pt. 11): S. 3216–3223.

Jin, C.; Flavell, R. A.:»Innate Sensors of Pathogen and Stress: Linking Inflammation to Obesity«. In: J Allergy Clin Immunol. 2013 August; 132 (2): S. 287-94.

Jirillo, E. et al.:»Healthy Effects Exerted by Prebiotics, Probiotics, and Symbiotics with Special Reference to Their Impact on the Immune System«. In: Int J Vitam Nutr Res. 2012 June; 82 (3): S. 200–208.

Jones, M. L. et al.:»Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus Reuteri NCIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults«. In: British Journal of Nutrition. 2012; 107 (10): S. 1505–1513.

Jumpertz, R. et al.:»Energy-Balance Studies Reveal Associations Between Gut Microbes, Caloric Load, and Nutrient Absorption in Humans«. In: Am J Clin Nutr. 2011; 94 (1): S. 58–65.

Katz, S. E.: The Art of Fermentation: An In-Depth Exploration of Essential Concepts and Processes from Around the World. Chelsea: Chelsea Green Publishing, 2012.

Katz, S. E.: Wild Fermentation: The Flavor, Nutrition, and Craft of Live-Culture Foods Reclaiming Domesticity from a Consumer Culture. Chelsea: Chelsea Green Publishing, 2011.

Kountouras, J. et al.:»Helicobacter Pylori Infection and Parkinson’s Disease: Apoptosis as an Underlying Common Contributor«. In: Eur J Neurol. 2012 June; 19 (6): S. e56.

Krznarica, Željko et al.:»Gut Microbiota and Obesity«. In: Dig Dis. 2012; 30: S. 196–200.

Kumar, M. et al.:»Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases«. In: Exp Diabetes Res. 2012; 2012: 902917.

Macfarlane, G. T. et al.:»Bacterial Metabolism and Health-Related Effects of Galactooligosaccharides and Other Prebiotics«. In: J Appl Microbiol. 2008 February; 104 (2): S. 305–344.

Mann, G. V. et al.:»Atherosclerosis in the Masai«. In: American Journal of Epidemiology. 1972; 95 (1): S. 26–37.

Marshall, B. J.:»Unidentified Curved Bacillus on Gastric Epithelium in Active Chronic Gastritis«. In: Lancet. 1983 June 4; 1 (8336): S. 1273 ff. Martinson, V. G. et al.:»A Simple and Distinctive Microbiota Associated with Honey Bees and Bumble Bees«. In: Mol Ecol. 2011 February; 20 (3): S. 619–628.

Matamoros, S. et al.:»Development of Intestinal Microbiota in Infants and its Impact on Health«. In: Trends Microbiol. 2013 April; 21 (4): S. 167–173.

Moodley, Y. et al.:»The Peopling of the Pacific from a Bacterial Perspective«. In: Science. 2009 January 23; 323 (5913): S. 527–530.

Mori, K. et al.:»Does the Gut Microbiota Trigger Hashimoto’s Thyroiditis?«. In: Discov Med. 2012 November; 14 (78): S. 321–326.

Musso, G. et al.:»Gut Microbiota as a Regulator of Energy Homeostasis and Ectopic Fat Deposition: Mechanisms and Implications for Metabolic Disorders«. In: Current Opinion in Lipidology. 2010; 21 (1): S. 76–83. Nagpal, R. et al.:»Probiotics, their Health Benefits and Applications for Developing Healthier Foods: A Review«. In: FEMS Microbiol Lett. 2012 September; 334 (1): S. 1-15.

Nakamura, Y. K.; Omaye, S. T.:»Metabolic Diseases and Proand Prebiotics: Mechanistic Insights«. In: Nutr Metab (Lond). 2012 June 19; 9 (1): S. 60.

Nicola, J. P. et al.:»Functional Toll-like Receptor 4 Conferring Lipopolysaccharide Responsiveness is Expressed in Thyroid Cells«. In: Endocrinology. 2009 January; 150 (1): S. 500–508.

Nielsen, H. H. et al.:»Treatment for Helicobacter Pylori Infection and Risk of Parkinson’s Disease in Denmark«. In: Eur J Neurol. 2012 June; 19 (6): S. 864–869.

Norris, V. et al.:»Bacteria Control Host Appetites«. In: J Bacteriol. 2013 February; 195 (3): S. 411–416.

Okusaga, O.; Postolache, T. T.:»Toxoplasma Gondii, the Immune System, and Suicidal Behavior«. In: Dwivedi, Y. (Hrsg.): The Neurobiological Basis of Suicide. Boca Raton, Florida: CRC Press, 2012: S. 159–194.

Ottman, N. et al.:»The Function of our Microbiota: Who Is Out There and What Do They Do?«. In: Front Cell Infect Microbiol. 2012 August 9; 2: S. 104.

Pavlolvíc, N. et al.:»Probiotics-Interactions with Bile Acids and Impact on Cholesterol Metabolism«. In: Appl Biochem Biotechnol. 2012; 168: S. 1880–1895.

Petrof, E. O. et al.:»Stool Substitute Transplant Therapy for the Eradication of Clostridium Diffi le Infection: ›RePOOPulating‹ the Gut«. In: Microbiome. 2013 January 9; 1 (1): S. 3.

Reading, N. C.; Kasper, D. L.:»The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis«. In: Front Microbiol. 2011 July 7; 2: S. 148.

Roberfroid, M. et al.:»Prebiotic Effects: Metabolic and Health Benefits«. In: Br J Nutr. 2010 August; 104 (Suppl. 2): S. S1-S63.

Sanders, M. E. et al.:»An Update on the Use and Investigation of Probiotics in Health and Disease«. In: Gut. 2013; 62 (5): S. 787–796. Sanza, Y. et al.:»Understanding the Role of Gut Microbes and Probiotics in Obesity: How Far Are We?«. In: Pharmacol Res. 2013 March; 69 (1): S. 144–155.

Schmidt, C.:»The Startup Bugs«. In: Nat Biotechnol. 2013 April; 31 (4): S. 279–281.

Scholz-Ahrens, K. E. et al.:»Prebiotics, Probiotics, and Synbiotics Affect Mineral Absorption, Bone Mineral Content, and Bone Structure«. In: J Nutr. 2007 March; 137 (3 Suppl. 2): S. 838S-846S. Schwarz, S. et al.:»Horizontal versus Familial Transmission of Helicobacter Pylori«. In: PLoS Pathog. 2008 October; 4 (10): S. e1000180. Shen, J. et al.:»The Gut Microbiota, Obesity and Insulin Resistance«. In: Mol Aspects Med. 2013 February; 34 (1): S. 39–58.

Starkenmann, C. et al.:»Olfactory Perception of Cysteine-S-Conjugates from Fruits and Vegetables«. In: J Agric Food Chem. 2008 October 22; 56 (20): S. 9575–9580.

Stowell, S. R. et al.:»Innate Immune Lectins Kill Bacteria Expressing Blood Group Antigen«. In: Nat Med. 2010 March; 16 (3): S. 295–301. Tängdén, T. et al.:»Foreign Travel Is a Major Risk Factor for Colonization with Escherichia Coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: A Prospective Study with Swedish Volunteers«. In: Antimicrob Agents Chemother. 2010 September; 54 (9): S. 3564–3568. Teixeira, T. F. et al.:»Potential Mechanisms for the Emerging Link Between Obesity and Increased Intestinal Permeability«. In: Nutr Res. 2012 September; 32 (9): S. 637–647.

Torrey, E. F. et al.:»Antibodies to Toxoplasma Gondii in Patients With Schizophrenia: A Meta-Analysis«. In: Schizophr Bull. 2007 May; 33 (3): S. 729–736.

Tremaroli, V.; Bäckhed, F.:»Functional Interactions Between the Gut Microbiota and Host Metabolism. In: Nature. 2012 September 13; 489 (7415): S. 242–249.

Turnbaugh, P. J.; Gordon, J. I.:»The Core Gut Microbiome, Energy Balance and Obesity«. In: J Physiol. 2009; 587 (17): S. 4153–4158. de Vrese, M.; Schrezenmeir, J.:»Probiotics, Prebiotics, and Synbiotics«. In: Adv Biochem Engin/Biotechnol. 2008; 111: S. 1-66.

de Vriese, J.:»Medical Research. The Promise of Poop«. In: Science. 2013 August 30; 341 (6149): S. 954–957.

Vyas, U.; Ranganathan, N.:»Probiotics, Prebiotics, and Synbiotics: Gut and Beyond«. In: Gastroenterol Res Pract. 2012; 2012: 872716.

Webster, J. P. et al.:»Effect of Toxoplasma Gondii upon Neophobic Behaviour in Wild Brown Rats, Rattus norvegicus«. In: Parasitology. 1994 July; 109 (Pt. 1): S. 37–43.